Welcome words

Dear Colleagues,

It is with great excitement that we introduce CVIR Oncology, the first and only journal dedicated entirely to the advancement of interventional oncology and its role in cancer care and patient management. Over the past two decades, interventional oncology has emerged as one of the most innovative and rapidly evolving fields in medicine. As image-guided, minimally invasive therapies continue to transform cancer treatment, the need for a specialized platform to showcase cutting-edge research has never been greater.

Having been deeply involved in the development of interventional oncology for many years, I have witnessed firsthand how our field has evolved from pioneering techniques to becoming an integral part of modern cancer therapy. It has been a privilege to contribute to this progress, and I am immensely proud to now take the next step by launching CVIR Oncology. This journal represents a true milestone, made possible through the dedication and expertise of an outstanding team of renowned international leaders in interventional oncology and radiology. Together, we are committed to shaping the future of our specialty and ensuring that impactful research reaches the global community.

A Dedicated Platform for Interventional Oncology

CVIR Oncology is committed to providing a global, open-access forum for the dissemination of high-quality research, enabling researchers, clinicians, and multidisciplinary cancer care teams to share knowledge and drive innovation.

Why Publish with CVIR Oncology?
• Exclusive focus on interventional oncology – As the only journal dedicated entirely to this field, CVIR Oncology highlights the latest advancements, techniques, and technologies shaping cancer treatment.
• Global reach through open access – Ensuring that your work is freely accessible to researchers, clinicians, journalists, and the wider medical community, maximizing visibility and impact.
• Rapid and continuous publication – A streamlined peer-review process allows for timely dissemination of new research.
• Facilitating multidisciplinary collaboration – Connecting interventional radiologists, oncologists, and cancer care teams to foster knowledge exchange and innovation.
• Integral to the CIRSE community – Strengthening ties within a trusted network of professionals dedicated to improving patient outcomes.
• Leadership by global experts – Under the guidance of Prof. Thomas Helmberger and a distinguished editorial board, ensuring excellence in peer review and diverse perspectives.

Welcoming Interdisciplinary and Translational Research
While our primary focus is on interventional oncology, we strongly encourage contributions from all medical fields engaged in interdisciplinary and translational work in oncology. The future of cancer care relies on collaboration between radiologists, oncologists, surgeons, pathologists, biomedical engineers, and other specialists, and we welcome research that bridges these disciplines to drive innovation and improve patient outcomes.

Welcoming Diverse Contributions
CVIR Oncology accepts a wide range of article types, including:
• Original research
• Review articles
• Study protocols
• Short communications
• Editorials
• Letters
• Commentaries
• Case reports
• New technologies

Join Us in Advancing Interventional Oncology!
We invite you to be part of this exciting journey by contributing your research and insights to CVIR Oncology. Whether you are working in interventional oncology or in a related discipline seeking to collaborate across specialties, your work has a home in our journal.

Together, we can continue to push the boundaries of cancer treatment and drive meaningful advancements in patient care. We look forward to your submissions and to shaping the future of our field—one innovation at a time.

With best regards,
on behalf of the Editors of CVIR Oncology